HIGHLIGHTS
- who: Christopher James from the Guizhou Provincial People`s Hospital, China Universidad San Francisco de Quito have published the article: Impact of intravesical Bacillus Calmette-Guu00e9rin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer, in the Journal: (JOURNAL)
- what: The authors aim to characterize changes that occur in the bladder microbiome over the course of intravesical therapy and assess whether these changes correlate with outcomes in patients with NMIBC. The authors sought to evaluate changes to the bladder microbiome at various timepoints throughout induction intravesical therapy. The study showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.